Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17274
Country/Region: Botswana
Year: 2017
Main Partner: University of Maryland
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $5,178,272 Additional Pipeline Funding: $507,648

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $998,200
Sexual Prevention: Other Sexual Prevention (HVOP) $425,000
Treatment: Adult Treatment (HTXS) $3,755,072
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
PMTCT_ART Already on ART at beginning of current pregnancy 2018 3,995
PMTCT_ART Already on ART at beginning of current pregnancy 2018 27
PMTCT_ART New on ART 2018 1,445
PMTCT_ART New on ART 2018 10
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 5,440
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 37
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 22,793
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 192
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 5,478
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 49
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 2,998
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 27
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,439
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 22
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 23
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 18
PMTCT_STAT By Age (Numerator): : 15-19 2018 2,401
PMTCT_STAT By Age (Numerator): 15-19 2018 20
PMTCT_STAT By Age (Numerator): 20-24 2018 7,500
PMTCT_STAT By Age (Numerator): 20-24 2018 63
PMTCT_STAT By Age (Numerator): 25-49 2018 12,854
PMTCT_STAT By Age (Numerator): 25-49 2018 109
PMTCT_STAT By Age (Numerator): 50+ 2018 38
PMTCT_STAT By known positives: 10-14 2018 4
PMTCT_STAT By known positives: 15-19 2018 493
PMTCT_STAT By known positives: 20-24 2018 1,514
PMTCT_STAT By known positives: 25-49 2018 2,558
PMTCT_STAT By new negatives: 10-14 2018 11
PMTCT_STAT By new negatives: 15-19 2018 1,820
PMTCT_STAT By new negatives: 20-24 2018 5,630
PMTCT_STAT By new negatives: 25-49 2018 9,563
PMTCT_STAT By new negatives: 50+ 2018 29
PMTCT_STAT By new positives: 10-14 2018 1
PMTCT_STAT By new positives: 15-19 2018 126
PMTCT_STAT By new positives: 20-24 2018 386
PMTCT_STAT By new positives: 25-49 2018 658
PMTCT_STAT By Number of known positives: 15-19 2018 4
PMTCT_STAT By Number of known positives: 20-24 2018 12
PMTCT_STAT By Number of known positives: 25-49 2018 19
PMTCT_STAT By Number of new negative: 15-19 2018 16
PMTCT_STAT By Number of new negative: 20-24 2018 49
PMTCT_STAT By Number of new negative: 25-49 2018 83
PMTCT_STAT By Number of new positives: 15-19 2018 1
PMTCT_STAT By Number of new positives: 20-24 2018 3
PMTCT_STAT By Number of new positives: 25-49 2018 5
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 22,793
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 192
PMTCT_STAT_den By Age (Denominator): <15-19 2018 21
PMTCT_STAT_den By Age (Denominator): 15-19 2018 2,525
PMTCT_STAT_den By Age (Denominator): 20-24 2018 7,889
PMTCT_STAT_den By Age (Denominator): 20-24 2018 66
PMTCT_STAT_den By Age (Denominator): 25-49 2018 13,532
PMTCT_STAT_den By Age (Denominator): 25-49 2018 115
PMTCT_STAT_den By Age (Denominator): 50+ 2018 46
TX_CURR Aggregated Age/Sex: <15 Female 2018 2,227
TX_CURR Aggregated Age/Sex: <15 Male 2018 2,342
TX_CURR Aggregated Age/Sex: 15+ Female 2018 123,515
TX_CURR Aggregated Age/Sex: 15+ Male 2018 70,701
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 198,784
TX_CURR Sum of Aggregated Age/Sex <15 2018 4,569
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 194,216
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 198,785
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 365
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 286
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 15,912
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 20,522
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 37,085
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 37,085
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 155,998
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 148,240
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,691
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,774
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 92,175
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 52,600
TX_PVLS Numerator: Indication: Routine 2018 148,240
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,776
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,862
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 96,988
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 55,365
TX_PVLS_den Denominator: Indication: Routine 2018 155,998
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 254
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 273
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 18,906
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 11,764
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 31,198
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 34,682
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 62
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 279
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 304
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 21,016
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 13,081
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 175,585
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 3,515
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 22
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 21
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 2,213
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 1,257
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,639
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 1,637
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 109,690
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 62,616
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 42,139
TX_TB_den Denominator: By Screen Result: Negative 2018 105,353
TX_TB_den Denominator: By Screen Result: Positive 2018 70,232
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 42,139